Diabetes

News

Under pressure from Trump, Lilly hikes Mounjaro prices in UK

Lilly has said it will raise the UK list price of its diabetes and obesity therapy Mounjaro to bring it into parity with other European markets.

News

Novo Nordisk weakens again on interim results readout

Novo Nordisk's already depressed share price has fallen again this morning, despite reporting an 18% increase in sales in the first half of this year.

News

Lilly trumpets heart health data with Mounjaro

Eli Lilly has raised the stakes in its rivalry with Novo Nordisk on GLP-1 drugs for diabetes, with new data for Mounjaro on cardiovascular outcomes.

News

Novo Nordisk slumps as it cuts sales forecast, names new CEO

Novo Nordisk has a new CEO, facing an uphill battle to restore the fortunes of its US business as diabetes and obesity drugs come under pressure.

News

'Diabetes Barbie' launches with medtech accessories

Barbie just took a step forward for inclusivity and representation with the launch of a doll with type 1 diabetes.

News

Boehringer raises hope of oral drug for diabetic eye disease

Boehringer has started a phase 2 trial of an oral therapy that could help people with diabetic macular oedema avoid regular injections into the eye.

Under pressure from Trump, Lilly hikes Mounjaro prices in UK

Novo Nordisk weakens again on interim results readout

Lilly trumpets heart health data with Mounjaro

Novo Nordisk slumps as it cuts sales forecast, names new CEO

'Diabetes Barbie' launches with medtech accessories

Boehringer raises hope of oral drug for diabetic eye disease

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Diabetes

Editor's Picks